Anthropic Appoints New Board Member

Anthropic has added a new member to its board of directors. Novartis CEO Vas Narasimhan has joined the company's board. This move is seen as a significant step for Anthropic to strengthen its collaborations in the healthcare sector. Vas Narasimhan's experience and expertise could be influential in the company's growth. With this move, Anthropic aims to secure a stronger position in the healthcare industry. Not investment advice.

📊 NVS — Piyasa Yorumu

■ neutral · 60%

Technical indicators present a mixed picture. The price is moving within a consolidation area, closing above the 20-day moving average but below the 50-day average. The RSI is in neutral territory, and while the MACD is below its signal line, it may show signs of convergence. The given news headline does not appear to have a direct connection to NVS (Novartis) shares, and therefore no significant short-term price impact is expected. Overall, the stock may follow a neutral trend in the short term.

RSI 14

50.8

MACD

-0.21

24h Δ

-1.13%

Canlı Grafikler